InMed Pharmaceuticals (INM) Current Deferred Revenue (2021 - 2023)
InMed Pharmaceuticals (INM) posted quarterly Current Deferred Revenue of $28656.0 for Q4 2023, up 77.21% year-over-year from $16171.0 in Q4 2022, and up 77.21% quarter-over-quarter from $16171.0 in Q2 2023.
InMed Pharmaceuticals (INM) Current Deferred Revenue (2021 - 2023) Analysis & Trends
InMed Pharmaceuticals' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $28656.0 for Q4 2023.
- In Q4 2023, Current Deferred Revenue rose 77.21% year-over-year to $28656.0; the TTM figure through Dec 2023 stood at $28656.0 (up 77.21% YoY), while the FY2023 annual figure was $16171.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2023 stood at $28656.0, up from $16171.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $28656.0 in Q4 2023, with the low at $8390.0 in Q4 2021.
- The 3-year median for Current Deferred Revenue is $16171.0 (2022), against an average of $15737.3.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue soared 92.74% in 2022, then soared 77.21% in 2023.
- InMed Pharmaceuticals' Current Deferred Revenue stood at $8390.0 in 2021, then jumped by 92.74% to $16171.0 in 2022, then jumped by 77.21% to $28656.0 in 2023.
- Business Quant data shows INM's Current Deferred Revenue at $28656.0 in Q4 2023, $16171.0 in Q2 2023, and $16171.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28,656.00 |
| Jun 30, 2023 | 16,171.00 |
| Mar 31, 2023 | 16,171.00 |
| Dec 31, 2022 | 16,171.00 |
| Sep 30, 2022 | 15,700.00 |
| Mar 31, 2022 | 8,902.00 |
| Dec 31, 2021 | 8,390.00 |